Stock CGEM CULLINAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cullinan Therapeutics, Inc.

Equities

CGEM

US2300311063

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
24.13 USD +6.53% Intraday chart for Cullinan Therapeutics, Inc. +4.14% +136.80%
May. 15 Cullinan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 15 Cullinan Therapeutics, Inc. Announces Board Changes CI

Evolution of the average Target Price on Cullinan Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c559.o2OL2ILKDzi0XM4yrl0QnlkklHb5Snd1upNGke2HPAE.yRnxu-6yY17WKotZzTB1rjtA2BzNHUEn9vEz1KfxXWDoL-O1ur5oaOIehw~cc3ce2f1bb82b9190cdc9524de387ad7

Analyst Recommendations on Cullinan Therapeutics, Inc.

Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing MT
CULLINAN ONCOLOGY : Morgan Stanley Adjusts Cullinan Oncology's Price Target to $43 From $40, Maintains Overweight Rating MT
CULLINAN ONCOLOGY : HC Wainwright Adjusts Cullinan Management PT to $55 From $48, Maintains Buy Rating MT
CULLINAN ONCOLOGY : SVB Leerink Adjusts Price Target on Cullinan Management to $54 From $48, Maintains Outperform Rating MT
CULLINAN ONCOLOGY : Morgan Stanley Upgrades Cullinan Management to Overweight from Equalweight, Sets $40 Price Target MT
CULLINAN ONCOLOGY : Morgan Stanley Adjusts Price Target on Cullinan Management to $40 From $38, Maintains Equal-Weight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
24.13 USD
Average target price
33 USD
Spread / Average Target
+36.76%
High Price Target
40 USD
Spread / Highest target
+65.77%
Low Price Target
28 USD
Spread / Lowest Target
+16.04%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cullinan Therapeutics, Inc.

Morgan Stanley
SVB Leerink
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CGEM Stock
  4. Consensus Cullinan Therapeutics, Inc.